CGON
NASDAQCG Oncology Inc.
Price$71.83+1.61 (+2.29%)
01:30 PM07:45 PM
News · 26 weeks50-9%
2026-01-182026-07-12
Mix3490d
- Insider13(38%)
- SEC Filings11(32%)
- Other8(24%)
- Offering1(3%)
- Analyst1(3%)
Latest news
25 items- INSIDERDirector Post Leonard E exercised 1,000 shares at a strike of $0.60 and sold $71,170 worth of shares (1,000 units at $71.17) as part of a pre-agreed trading plan (SEC Form 4)4 - CG Oncology, Inc. (0001991792) (Issuer)
- INSIDERDirector Mulay James exercised 24,165 shares at a strike of $26.63 and sold $1,816,241 worth of shares (24,165 units at $75.16) as part of a pre-agreed trading plan (SEC Form 4)4 - CG Oncology, Inc. (0001991792) (Issuer)
- SECSEC Form 144 filed by CG Oncology Inc.144 - CG Oncology, Inc. (0001991792) (Subject)
- SECSEC Form 144 filed by CG Oncology Inc.144 - CG Oncology, Inc. (0001991792) (Subject)
- INSIDERDirector Liu Brian Guan-Chyun bought $24,814,454 worth of shares (371,085 units at $66.87) (SEC Form 4)4 - CG Oncology, Inc. (0001991792) (Issuer)
- INSIDERDirector Post Leonard E exercised 5,000 shares at a strike of $0.60 and sold $350,000 worth of shares (5,000 units at $70.00) as part of a pre-agreed trading plan (SEC Form 4)4 - CG Oncology, Inc. (0001991792) (Issuer)
- PRThe New War on Cancer: Four Public Companies Helping Lead a Medical RevolutionDENVER, June 25, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) – Cancer treatment is undergoing one of the most significant transformations in modern medical history. For decades, physicians relied primarily on surgery, radiation, and chemotherapy. While those therapies have saved countless lives, a new generation of biotechnology companies is working to make cancer treatment smarter, more targeted, and potentially more effective. Rather than simply attacking rapidly dividing cells, researchers are developing therapies designed to identify specific genetic mutations, harness the immune system, and deliver treatments directly to cancer cells while minimizing damage to healthy tissue. Seve
- SECSEC Form 144 filed by CG Oncology Inc.144 - CG Oncology, Inc. (0001991792) (Subject)
- INSIDERDirector Post Leonard E sold $325,000 worth of shares (5,000 units at $65.00) as part of a pre-agreed trading plan and exercised 5,000 shares at a strike of $0.60 (SEC Form 4)4 - CG Oncology, Inc. (0001991792) (Issuer)
- SECSEC Form 144 filed by CG Oncology Inc.144 - CG Oncology, Inc. (0001991792) (Subject)
- INSIDERDirector Mulay James exercised 1,964 shares at a strike of $9.64 and sold $118,076 worth of shares (1,964 units at $60.12) as part of a pre-agreed trading plan (SEC Form 4)4 - CG Oncology, Inc. (0001991792) (Issuer)
- SECSEC Form 8-K filed by CG Oncology Inc.8-K - CG Oncology, Inc. (0001991792) (Filer)
- INSIDERSEC Form 4 filed by Director Liu Brian Guan-Chyun4 - CG Oncology, Inc. (0001991792) (Issuer)
- INSIDERSEC Form 4 filed by Director Tong Victor Edward Jr4 - CG Oncology, Inc. (0001991792) (Issuer)
- INSIDERSEC Form 4 filed by Director Mulay James4 - CG Oncology, Inc. (0001991792) (Issuer)
- INSIDERSEC Form 4 filed by Director Graf Susan E4 - CG Oncology, Inc. (0001991792) (Issuer)
- INSIDERSEC Form 4 filed by Director Rossi Christina4 - CG Oncology, Inc. (0001991792) (Issuer)
- INSIDERDirector Post Leonard E exercised 1,000 shares at a strike of $0.60 and sold $54,500 worth of shares (1,000 units at $54.50) as part of a pre-agreed trading plan (SEC Form 4)4 - CG Oncology, Inc. (0001991792) (Issuer)
- SECSEC Form 144 filed by CG Oncology Inc.144 - CG Oncology, Inc. (0001991792) (Subject)
- PRCG Oncology to Present at Upcoming Investor Conferences in JuneDALLAS, May 28, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ:CGON) today announced that Arthur Kuan, Chairman, President & Chief Executive Officer, will participate in fireside chat presentations at the Jefferies Global Healthcare Conference and the Goldman Sachs 47th Annual Global Healthcare Conference this month. The details of the upcoming events are as follows: Jefferies Global Healthcare Conference Date: Wednesday, June 3, 2026Presentation Time: 10:30-11:00 AM ETLocation: New York, New York Goldman Sachs 47th Annual Global Healthcare Conference Date: Tuesday, June 9, 2026Presentation Time: 2:40-3:15 PM ETLocation: Miami, Florida Interested parties may access the live audio we
- SECCG Oncology Inc. filed SEC Form 8-K: Leadership Update8-K - CG Oncology, Inc. (0001991792) (Filer)
- ANALYSTWolfe Research initiated coverage on CG OncologyWolfe Research initiated coverage of CG Oncology with a rating of Peer Perform
- PRSUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship AwardPatrick Hensley, MD and Daniel Joyce, MD, MS each received a grant up to $50,000.00 to support the development of outstanding clinical cancer research to improve the treatment of NMIBCLast year's awardees recently presented their research at the SUO 2026 Annual Meeting at the AUA SCHAUMBURG, Ill. and DALLAS, May 19, 2026 (GLOBE NEWSWIRE) -- The Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC), a national alliance of leading academic and community based uro-oncologists, and CG Oncology, Inc. (NASDAQ:CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder canc
- SECSEC Form SCHEDULE 13G filed by CG Oncology Inc.SCHEDULE 13G - CG Oncology, Inc. (0001991792) (Subject)
- SECSEC Form SCHEDULE 13G filed by CG Oncology Inc.SCHEDULE 13G - CG Oncology, Inc. (0001991792) (Subject)
CGON FAQ
6 questionsWhere does CGON stock trade?
CG Oncology Inc. (CGON) is listed on NASDAQ.What sector and industry is CGON in?
CG Oncology Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did CG Oncology Inc. go public?
CG Oncology Inc. (CGON) completed its IPO in 2024.What are analysts saying about CGON?
CG Oncology Inc. has had 8 recent analyst actions on file. The most recent action was from Wolfe Research: Peer Perform on 2026-05-19. Recent price targets range from $2300.00 to $4100.00.What companies are similar to CGON?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare CGON side-by-side with any of them on Quantisnow.How can I track CGON on Quantisnow?
Quantisnow aggregates CG Oncology Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CGON to receive live email and push alerts on every new disclosure.